ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
This Quarter Return
+15.27%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$368M
AUM Growth
+$368M
Cap. Flow
+$60.7M
Cap. Flow %
16.49%
Top 10 Hldgs %
38.61%
Holding
80
New
27
Increased
20
Reduced
13
Closed
19

Top Buys

1
SNY icon
Sanofi
SNY
$13.5M
2
CVS icon
CVS Health
CVS
$12.6M
3
KIDS icon
OrthoPediatrics
KIDS
$9.9M
4
AHCO icon
AdaptHealth
AHCO
$9.16M
5
AZN icon
AstraZeneca
AZN
$9.01M

Top Sells

1
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$39.1M
2
ACRS icon
Aclaris Therapeutics
ACRS
$16.9M
3
SIBN icon
SI-BONE Inc
SIBN
$7.62M
4
SNN icon
Smith & Nephew
SNN
$7.55M
5
OMI icon
Owens & Minor
OMI
$5.28M

Sector Composition

1 Healthcare 89.39%
2 Industrials 0.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XFOR icon
51
X4 Pharmaceuticals
XFOR
$70M
$1.31M 0.34%
+151,996
New +$1.31M
BLU
52
DELISTED
BELLUS Health Inc.
BLU
$1.21M 0.31%
+313,835
New +$1.21M
FATE icon
53
Fate Therapeutics
FATE
$115M
$1.11M 0.29%
13,432
-53,153
-80% -$4.38M
FBRX icon
54
Forte Biosciences
FBRX
$138M
$946K 0.25%
+27,591
New +$946K
NVRO
55
DELISTED
NEVRO CORP.
NVRO
$899K 0.23%
+6,442
New +$899K
STRM
56
DELISTED
Streamline Health Solutions
STRM
$796K 0.21%
+388,417
New +$796K
BOLT icon
57
Bolt Biotherapeutics
BOLT
$9.29M
$585K 0.15%
+17,777
New +$585K
TARS icon
58
Tarsus Pharmaceuticals
TARS
$2.44B
$456K 0.12%
+14,143
New +$456K
LBPH
59
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$267K 0.07%
+16,327
New +$267K
PRAH
60
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-21,590
Closed -$2.71M
QTNT
61
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-226,593
Closed -$1.18M
FSTX
62
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-20,445
Closed -$202K
EUCRU
63
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
– –
-195,000
Closed -$2.08M
STRO icon
64
Sutro Biopharma
STRO
$85.6M
– –
-172,047
Closed -$3.74M
SRPT icon
65
Sarepta Therapeutics
SRPT
$1.98B
– –
-28,378
Closed -$4.84M
SNN icon
66
Smith & Nephew
SNN
$16.2B
– –
-179,138
Closed -$7.55M
SLDB icon
67
Solid Biosciences
SLDB
$448M
– –
-45,682
Closed -$346K
SIBN icon
68
SI-BONE Inc
SIBN
$700M
– –
-254,907
Closed -$7.62M
PRTA icon
69
Prothena Corp
PRTA
$452M
– –
-151,820
Closed -$1.82M
PNTG icon
70
Pennant Group
PNTG
$853M
– –
-18,227
Closed -$1.06M
MRK icon
71
Merck
MRK
$210B
– –
-14,919
Closed -$1.22M
MBIO icon
72
Mustang Bio
MBIO
$11.1M
– –
-892,027
Closed -$3.38M
KNSA icon
73
Kiniksa Pharmaceuticals
KNSA
$2.63B
– –
-133,648
Closed -$2.36M
HUM icon
74
Humana
HUM
$37.5B
– –
-7,504
Closed -$3.08M
CI icon
75
Cigna
CI
$80.2B
– –
-25,085
Closed -$5.22M
1 2
3
4